REFRACTORY PLASMA CELL MYELOMA
Clinical trials for REFRACTORY PLASMA CELL MYELOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY PLASMA CELL MYELOMA trials appear
Sign up with your email to follow new studies for REFRACTORY PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail shows promise for Hard-to-Treat myeloma
Disease control OngoingThis study tests a combination of three drugs (isatuximab, carfilzomib, and pomalidomide) in about 5 adults with multiple myeloma that has come back or stopped responding to treatment. The goal is to see how well the drugs work together to shrink or control the cancer. This is no…
Matched conditions: REFRACTORY PLASMA CELL MYELOMA
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated May 01, 2026 18:42 UTC
-
Virus-Enhanced cocktail takes on Hard-to-Treat myeloma
Disease control OngoingThis study tests a combination of standard chemotherapy (bortezomib, dexamethasone), an immunotherapy (pembrolizumab), and a lab-modified virus (pelareorep) in people with multiple myeloma that has returned or stopped responding to treatment. The goal is to see if adding the viru…
Matched conditions: REFRACTORY PLASMA CELL MYELOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 01, 2026 18:41 UTC